Physician profile
Matthew L Smith
NPI 1154415149
$3,509.54
in general payments reported to CMS, 2019-2025
33 companies · $430 in 2025
The $430 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $347 · 2021: $608 · 2022: $553 · 2023: $592 · 2024: $495 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.46 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $873.67 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Pfizer INC. | $314.25 | 2019-2025 | |
| Astellas Pharma US INC | $244.10 | 2020-2024 | Veozah |
| Daiichi Sankyo INC. | $239.36 | 2019-2025 | Injectafer |
| Mayne Pharma Commercial LLC | $238.02 | 2022-2025 | |
| Exeltis, USA INC. | $214.81 | 2019-2025 | Slynd |
| Organon LLC | $158.20 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $125.60 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $122.78 | 2019-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Axsome Therapeutics, INC. | $113.05 | 2023 | Auvelity |
| Myovant Sciences INC. | $96.02 | 2021-2022 | |
| Avion Pharmaceuticals | $91.67 | 2019-2022 | |
| Millicent US INC | $88.78 | 2025 | Intrarosa, Femring, Femlyv |
| Sage Therapeutics, LLC | $75.76 | 2023-2025 | Zurzuvae |
| Coopersurgical, INC. | $59.23 | 2019-2023 | Endosee |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $45.82 | 2020-2022 | |
| Minerva Surgical, INC | $41.86 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $40.16 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Amag Pharmaceuticals, INC. | $36.75 | 2019-2021 | |
| Davol INC. | $30.01 | 2025 | Arista |
| Merck Sharp & Dohme LLC | $29.85 | 2020-2021 | |
| Shield Therapeutics INC | $28.14 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $24.24 | 2025 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $23.57 | 2021-2022 | |
| Agile Therapeutics, INC. | $22.40 | 2022 | |
| Alydia Health | $20.79 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.94 | 2019 | |
| Scynexis, INC. | $18.80 | 2022 | |
| Duchesnay USA Incorporated | $17.11 | 2019 | |
| Coloplast Corp | $15.70 | 2019 | |
| Lupin INC. | $15.17 | 2021 | |
| Evofem Biosciences, INC. | $13.80 | 2021 | |
| Aspira Women'S Health INC | $11.13 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.